July 12th, 2010 by admin
Johnson & Johnson (JNJ.N) recalled more Tylenol and other over-the-counter drugs on Thursday after they were linked to a musty or moldy odor, expanding a recall the company started in January. J&J’s McNeil Consumer Healthcare unit said the latest recall involved 21 lots of medications, including Tylenol for children and adults, several forms of Benadryl allergy tablets and Motrin painkiller. But it did not say how many pieces were in each lot or give a total number of items involved. J&J spokeswoman Bonnie Jacobs said, “We do not have that information.”
Continue reading ‘J&J Recalls More Tylenol, over-the-counter drugs’
May 10th, 2010 by admin
The Johnson & Johnson children’s drug recall has spawned a congressional investigation, of the company’s performance on one side and of federal regulators on the other, the Washington Post reports. Spearheading the inquiry are Reps. Edolphus Towns and Darrell Issa, who head up the House Committee on Oversight and Government reform.
Continue reading ‘J&J Children’s Drug Recall – Congressional Investigation’
February 4th, 2010 by admin
Even though there are no safety issues related to AstraZeneca’s recall of 4.7 million doses of swine flu vaccine, other issues remain. In particular, the nasal spray version loses an unacceptable amount of potency while in storage. As a general rule of thumb, drugs and vaccines all lose potency over time. This is one of many reasons why vaccine potency is monitored even after doses become available for sale. There are also federal guidelines that stipulate a minimum level of potency that must be maintained.
Continue reading ‘4.7 Million Doses of Flu Vaccine Recalled by AstraZeneca’
